Parkinsons Flashcards
common age and gender in parkinsons
male
diagnosed age 66 usually
the four motor features
bradykinesia tremor at rest rigidity postural instability *must have bradykinesia
describe the tremor at rest
rhythmic
asymmetric - doesnt affect both sides equally
pill rolling
feet, lip, jaw
may disappear with voluntary movement and sleep
worsens with mental stress
describe the rigidity
lead pipe, cogwheel
neck, trunk, limbs
resistance to passive movement of the limbs
describe bradykinesia
slowness of all movements
difficulty initiating movement
describe postural instability
later presentation
shuffling gait
narrow base
freezing and falls
main difference in symptoms between motor cortex disorders
no muscle weakness
just a communication issue
other clinical features
depression dementia sleep disturbance difficultly smelling micrographia dysphagia lack of expression -hypomimia
what happens in the substantia nigra
low dopamine causes parkinsons
high dopamine causes dyskinesia
cells start to die in parkinsons
what is the substantion nigra responsible for
controls movements and connects to the motor cortex
how does the nigrostriatal pathway achieve smooth muscle movement
ach (inhibitory) and dopamine(excitatory) are in balance
what happens when there is much more ach than dopamine
movement becomes jerky and stiff
drugs that can cause parkinson like motor symptoms
typical antipsychotics - block all 4 pathways
atypical antipsycotics - selectively block dopamine in mesolimbic pathway
Gi agents - metoclopramide
SSRI
valproic acid
old antihypertensives
4 types of extrapyramidal symptoms
dystonia
akathisia
pseudoparkinsonism
tardive dyskinesia
risk factors for drug induced parkinsonism
old
femal
high dose of offending drug
history of movement disorder
signs its drug induce parkinsonism
symmetric presentation***
onset within a few weeks of starting drug
may take 2-6months to resolve after
what is drug induced neuroleptic malignant syndrome
life threatening
due to sudden decrease in dopaminergic transmission
dopamine blocker»_space;»decrease in dopamine transmission or sudden withdrawal from dopamine enhancer
FARM symptoms of neuroleptic malignant syndrome
fever
autonomic instability - sweat, HR, BP
rigidity
mental status changes
when do symptoms appear in parkinsons
once there is loss of 60-80% of pigmented neurons in the substantia nigra
5 ways to treat parkinsons
dopamine precursor dopamine agonist NMDA receptor antagonist COMT or MOAB inhibitor block acetylcholine
goals of therapy
preserve ability to perform activities of daily living
min AE and treatment complications
improve non motor features
what warrants therapu
when diability interferes with social emotional or work life